Yamada Hisakata, Dzhambazov Balik, Bockermann Robert, Blom Thomas, Holmdahl Rikard
Medical Inflammation Research, Department of Cell and Molecular Biology, Lund University, Lund, Sweden.
J Immunol. 2004 Oct 1;173(7):4729-35. doi: 10.4049/jimmunol.173.7.4729.
Lysine residues in type II collagen (CII) are normally hydroxylated and subsequently glycosylated in the chondrocyte. The immunodominant T cell epitope of CII involves such post-translationally modified lysine at position 264 that has been shown to be critical in the pathogenesis of murine collagen-induced arthritis and also in human rheumatoid arthritis. In this study we identified a line of transgenic mice expressing a TCR specific for hydroxylated rat CII epitope. They were crossed with transgenic mice expressing the rat CII epitope, either specifically in cartilage (MMC mice) or systemically (TSC mice), to analyze T cell tolerance to a post-translationally modified form of self-CII. The mechanism of T cell tolerance to the hydroxylated CII epitope in TSC mice was found to involve intrathymic deletion and induction of peripheral tolerance. In contrast, we did not observe T cell tolerance in the MMC mice. Analysis of CII prepared from rat or human joint cartilage revealed that most of the lysine 264 is glycosylated rather than remaining hydroxylated. Therefore, we conclude that the transient post-translationally modified form of cartilage CII does not induce T cell tolerance. This lack of T cell tolerance could increase the risk of developing autoimmune arthritis.
II型胶原蛋白(CII)中的赖氨酸残基通常在软骨细胞中发生羟基化,随后进行糖基化。CII的免疫显性T细胞表位涉及264位经翻译后修饰的赖氨酸,该赖氨酸已被证明在小鼠胶原诱导性关节炎以及人类类风湿性关节炎的发病机制中起关键作用。在本研究中,我们鉴定出了一群表达对羟基化大鼠CII表位具有特异性的T细胞受体(TCR)的转基因小鼠。将它们与分别在软骨中特异性表达(MMC小鼠)或全身表达(TSC小鼠)大鼠CII表位的转基因小鼠进行杂交,以分析T细胞对翻译后修饰形式的自身CII的耐受性。结果发现,TSC小鼠中T细胞对羟基化CII表位的耐受机制涉及胸腺内缺失和外周耐受性的诱导。相比之下,我们在MMC小鼠中未观察到T细胞耐受性。对大鼠或人类关节软骨制备的CII进行分析发现,大多数264位赖氨酸发生了糖基化,而非保持羟基化状态。因此,我们得出结论,软骨CII的短暂翻译后修饰形式不会诱导T细胞耐受性。这种T细胞耐受性的缺乏可能会增加自身免疫性关节炎的发病风险。